...
首页> 外文期刊>Human Molecular Genetics >A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer.
【24h】

A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer.

机译:XRCC2 R188H多态性位点在DNA损伤修复和乳腺癌中的潜在作用。

获取原文
获取原文并翻译 | 示例

摘要

An acquired genetic instability, resulting from the loss of some types of DNA repair, is an early event in the development of a subset of human cancers. The involvement of BRCA1 and BRCA2 in the homologous recombination repair (HRR) of double-strand breaks in DNA implicates this pathway in the suppression of breast cancer. A family of proteins related to human RAD51, including XRCC2, are essential components of this repair pathway. Using site-directed mutagenesis of XRCC2, we show that non-conservative substitution or deletion of amino acid 188 of XRCC2 can significantly affect cellular sensitivity to DNA damage, and that a polymorphic variant at this site (R188H ), present on 6% of chromosomes in the population, has a weak effect on damage sensitivity. We tested the hypothesis that the R188H polymorphism could be a low-penetrance susceptibility factor for breast cancer, by genotyping 521 women with breast cancer and a total of 895 control women. Carriage of the rare allele of XRCC2 R188H was associated with breast cancer overall [odds ratio 1.3; 95% confidence interval (CI)=(1.0, 1.8)] and when younger-onset cases with a positive family history were compared with older controls with no family history [odds ratio 1.9; 95% CI=(1.0, 3.8)]. These results support the hypothesis that subtle variation in DNA repair capacity may influence cancer susceptibility in the population.
机译:由于某些类型的DNA修复的丧失而导致的获得性遗传不稳定性,是人类癌症子集发展中的早期事件。 BRCA1和BRCA2参与DNA双链断裂的同源重组修复(HRR)牵涉此途径抑制乳腺癌。与人类RAD51相关的蛋白质家族(包括XRCC2)是该修复途径的重要组成部分。使用XRCC2的定点诱变,我们显示XRCC2氨基酸188的非保守取代或缺失可显着影响细胞对DNA损伤的敏感性,并且该位点的多态性变体(R188H)存在于6%的染色体上在人群中,对伤害敏感性的影响较弱。通过对521名乳腺癌女性和895名对照女性进行基因分型,我们检验了R188H多态性可能是乳腺癌的低渗透敏感性因素的假设。 XRCC2 R188H罕见等位基因的携带与乳腺癌总体相关[比值比为1.3; 95%的置信区间(CI)=(1.0,1.8)],并将家族史呈阳性的年轻发病病例与没有家族史的较早对照组进行比较[赔率比1.9; 95%CI =(1.0,3.8)]。这些结果支持以下假设:DNA修复能力的细微变化可能会影响人群中的癌症易感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号